| Literature DB >> 25195626 |
Giorgia Michelini1, Thalia C Eley, Alice M Gregory, Tom A McAdams.
Abstract
BACKGROUND: Anxiety and attention-deficit/hyperactivity (ADH) problems are common in adolescence, often co-occur, and are characterised by high heterogeneity in their phenotypic expressions. Although it is known that anxiety and ADH problems correlate, the relationships between subtypes of anxiety and ADH problems have been scarcely investigated.Entities:
Keywords: ADH problems; Anxiety; adolescence; genetics; twins
Mesh:
Year: 2014 PMID: 25195626 PMCID: PMC6607691 DOI: 10.1111/jcpp.12318
Source DB: PubMed Journal: J Child Psychol Psychiatry ISSN: 0021-9630 Impact factor: 8.982
Figure 1Full correlated factor solution for study variables. PAN, panic/agoraphobia; SOC, social anxiety; PHY, physical injury fears; OCS, obsessive‐compulsive symptoms; GAS, generalised anxiety symptoms; AP, attention problems. A1–A6, C1–C6 and E1–E6 respectively: additive genetic, shared environmental and nonshared environmental factors
Descriptive statistics for study variables and tests for sex and age effects
| Whole sample Mean ( | Males Mean ( | Females Mean ( | Min‐Max | Regression coefficients (CIs) | ||
|---|---|---|---|---|---|---|
| Sex | Age | |||||
| Panic/agoraphobia | 1.39 (2.23) | 1.11 (1.93) | 1.58 (2.39) | 0–18 | .21 (.11, .31) | −.03 (−.07, .01) |
| Separation anxiety symptoms | 2.72 (1.42) | 2.35 (1.18) | 2.97 (1.51) | 0–9 | .43 (.33, .54) | −.01 (−.06, .03) |
| Social anxiety | 4.38 (2.69) | 3.68 (2.47) | 4.84 (2.73) | 0–12 | .43 (.32, .53) | −.02 (−.03, .06) |
| Physical injury fears | 3.03 (2.51) | 2.10 (2.03) | 3.64 (2.61) | 0–15 | .61 (.51, .71) | −.01 (−.07, .02) |
| Obsessive‐compulsive symptoms | 3.06 (2.93) | 3.05 (2.90) | 3.07 (2.94) | 0–18 | .01 (−.01, .11) | −.01 (−.05, .02) |
| Generalised anxiety symptoms | 4.87 (2.91) | 4.12 (2.73) | 5.36 (2.92) | 0–18 | .42 (.32, .53) | .00 (−.04, .04) |
| Attention problems | 2.98 (2.19) | 2.93 (2.21) | 3.01 (2.17) | 0–12 | .04 (−.07, .14) | .00 (−.05, .04) |
| Hyperactivity/impulsivity | 1.91 (1.56) | 1.67 (1.46) | 2.06 (1.61) | 0–6 | .25 (.15, .36) | −.02 (−.06, .02) |
Means and standard deviations are on raw (nonregressed) data to be maximally relevant to the reader.
Sex and age effects were evaluated with linear regression models on standardised values using the cluster command to account for the nonindependence of observations (e.g. twin/sibling pairs).
Effect of sex at p < .001 level of significance representing higher scores in females (males = 0, females = 1).
Full correlations between the two ADH dimensions and anxiety subtypes, alongside partial correlations controlling for one ADH dimension at a time (95% confidence intervals)
| Full correlations | Partial correlations | |||
|---|---|---|---|---|
| AP | HYP | AP (control HYP) | HYP (control AP) | |
| Panic/agoraphobia | .39 (.35, .44) | .16 (.12, .22) | .34 (.30, .39) | .04 (−.02, .09) |
| Separation anxiety symptoms | −.05 (−.10, 0) | .02 (−.03, .07) | −.05 (−.10, 0) | .02 (−.03, .07) |
| Social anxiety | .33 (.28, .38) | −.04 (−.09, .01) | .36 (.31, .40) | −.19 (−.24, −.14) |
| Physical injury fears | .20 (.15, .25) | .09 (.04, .15) | .19 (.13, .24) | .03 (−.02, .08) |
| Obsessive‐compulsive symptoms | .41 (.36, .45) | .17 (.12, .22) | .34 (.29, .38) | .06 (.01, .11) |
| Generalised anxiety symptoms | .39 (.35, .44) | .17 (.12, .22) | .35 (.31, .39) | .03 (−.03, .08) |
| Attention problems | 1 | .32 (.27, .36) | 1 | – |
| Hyperactivity/impulsivity | 1 | – | 1 | |
AP, attention problems; HYP, hyperactivity/impulsivity.
Partial correlation between attention problems and anxiety subtypes controlling for hyperactivity/impulsivity problems.
Partial correlation between hyperactivity/impulsivity problems and anxiety subtypes controlling for attention problems.
Twin correlations (95% confidence intervals) for study variables by zygosity
| MZm | MZf | DZm/MMsibs | DZf/FFsibs | DZo/OSsibs | |
|---|---|---|---|---|---|
| Panic/agoraphobia | .53 (.35, .67) | .32 (.15, .47) | .12 (−.10, .31) | .18 (.03, .32) | .03 (−.10, .16) |
| Social Anxiety | .43 (.24, .59) | .34 (.17, .48) | .37 (.18, .54) | .24 (.09, .38) | .09 (−.04, .21) |
| Physical Injury Fears | .21 (.01, .41) | .41 (.25, .54) | .15 (−.05, .34) | .17 (.02, .31) | .07 (−.06, .19) |
| Obsessive‐compulsive Symptoms | .36 (.16, .53) | .45 (.30, .58) | .21 (−.01, .41) | .08 (−.08, .23) | .16 (.04, .28) |
| Generalised Anxiety Symptoms | .41 (.21, .57) | .48 (.33, .60) | .11 (−.11, .31) | .24 (.08, .39) | .10 (−.03, .23) |
| Attention Problems | .39 (.16, .60) | .44 (.28, .57) | .14 (−.08, .34) | .22 (.06, .36) | .26 (.13, .38) |
MZm, monozygotic male; MZf, monozygotic female; DZm/MMsibs, dizygotic male and male siblings; DZf/FFsibs, dizygotic female and female siblings; DZo/OSsibs, dizygotic opposite‐sex and opposite‐sex siblings.
Parameter estimates (95% confidence intervals) from multivariate modelling: genetic and nonshared environmental influences on each variable are given in bold on the diagonal, genetic and nonshared environmental correlations are given above the diagonal, and proportions of correlations attributable to genes and nonshared environment are given below the diagonal
| PAN | SOC | PHY | OCS | GAS | AP | |
|---|---|---|---|---|---|---|
|
| ||||||
| Panic/agoraphobia |
| .32 (.10, .51) | .20 (−.06, .41) | .73 (.57, .89) | .68 (.53, .81) | .53 (.35, .70) |
| Social anxiety | .33 (.10, .55) |
| .30 (.08, .49) | .52 (.35, .67) | .61 (.46, .75) | .45 (.28, .61) |
| Physical injury fears | .21 (−.05, .44) | .33 (.08, .56) |
| .49 (.29, .67) | .25 (.03, .44) | .12 (−.09, .31) |
| Obsessive‐compulsive symptoms | .54 (.38, .70) | .46 (.28, .62) | .55 (.31, .77) |
| .71 (.59, .83) | .58 (.43, .73) |
| Generalised anxiety symptoms | .45 (.30, .59) | .44 (.30, .57) | .30 (.04, .54) | .49 (.35, .61) |
| .51 (.35, .65) |
| Attention problems | .50 (.31, .68) | .54 (.33, .73) | .22 (−.18, .55) | .58 (.40, .74) | .55 (.36, .71) |
|
|
| ||||||
| Panic/agoraphobia |
| .33 (.23, .42) | .37 (.27, .46) | .32 (.22, .41) | .46 (.38, .55) | .32 (.21, .42) |
| Social anxiety | .67 (.45, .90) |
| .31 (.22, .41) | .34 (.25, .43) | .47 (.38, .55) | .26 (.15, .36) |
| Physical injury fears | .79 (.56, 1) | .67 (.44, .92) |
| .21 (.11, .31) | .34 (.23, .43) | .27 (.16, .37) |
| Obsessive‐compulsive symptoms | .46 (.30, .62) | .54 (.38, .72) | .45 (.23, .69) |
| .47 (.38, .55) | .28 (.18, .38) |
| Generalised anxiety symptoms | .55 (.41, .70) | .56 (.43, .70) | .70 (.46, .96) | .51 (.39, .65) |
| .32 (.21, .42) |
| Attention problems | .50 (.32, .69) | .46 (.27, .67) | .78 (.45, 1) | .42 (.26, .60) | .45 (.29, .64) |
|
Confidence intervals not spanning zero indicate significance.
PAN, panic/agoraphobia; SOC, social anxiety; PHY, physical injury fears; OCS, obsessive‐compulsive symptoms; GAS, generalised anxiety symptoms; AP, attention problems.